Shmuel Yaccoby
Affiliations: | Interdisciplinary Biomedical Sciences | University of Arkansas for Medical Sciences, United States |
Area:
Molecular Biology, OncologyGoogle:
"Shmuel Yaccoby"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ling W, Johnson SK, Mehdi SJ, et al. (2023) EDNRA-Expressing Mesenchymal Cells Are Expanded in Myeloma Interstitial Bone Marrow and Associated with Disease Progression. Cancers. 15 |
| Mehdi SJ, Ghatak K, Ling W, et al. (2023) Growth and dormancy control of myeloma cells by mesenchymal stem cells. Leukemia Research. 133: 107355 |
| Gai D, JP S, Shen X, et al. (2020) CST6 Is a Small Autocrine Molecule That Targets Myeloma Growth and Bone Destruction Blood. 136: 21-21 |
| Mikulasova A, Ashby C, Tytarenko RG, et al. (2019) Microhomology-mediated end joining drives complex rearrangements and over expression of MYC and PVT1 in multiple myeloma. Haematologica |
| Mehdi SJ, Johnson SK, Garg TK, et al. (2019) The mTOR Component, Rictor, Is Regulated By the Microenvironment to Control Dormancy and Proliferative States in Myeloma Cells Blood. 134: 4412-4412 |
| Mehdi SJ, Johnson SK, Epstein J, et al. (2018) Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes. British Journal of Haematology |
| Rasche L, Angtuaco EJ, Alpe TL, et al. (2018) The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma. Blood |
| Schinke C, Qu P, Mehdi SJ, et al. (2018) The pattern of Mesenchymal stem cell expression is an independent marker of outcome in multiple myeloma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Mehdi SJ, Johnson SK, Khan S, et al. (2018) Proliferation and Molecular Risk Score of Low Risk Myeloma Cells Are Increased in High Risk Microenvironment Via Augmented Bioavailability of Growth Factors Blood. 132: 1929-1929 |
| Mehdi SJ, Johnson SK, Epstein J, et al. (2018) Mesenchymal Stem Cells Gene Signature in High-Risk Myeloma Bone Marrow Linked to Suppression of Distinct IGFBP2-Expressing Small Adipocytes Blood. 132: 4448-4448 |